Wnt Signaling: The Many Interfaces of b-Catenin
Wnt signaling regulates virtually every cell fate decision during development. How can the same signal trigger such diverse events? Engaging different transcriptional machinery via different protein interfaces on the transcriptional co-activator b-catenin provides part of the answer. Mira I. Pronobis 1 and Mark Peifer 1,2,3, * A small subset of animal signaling pathways play inordinately important roles in development, with their transcriptional outputs shaping virtually every cell fate decision. Strikingly, inappropriate activation of these same powerful signaling pathways is implicated in most solid tumors. A central mystery in development is how the same signaling pathway directs diverse cell decisions. For example, Wnt signaling, one key pathway, modulates decisions as temporally and spatially diverse as dorsal-ventral axis formation, patterning of the mid/hindbrain, and adult bone mass homeostasis [1] . How can one pathway regulate the radically different sets of target genes required?
To answer this question, we must focus on the transcriptional Wnt effector, b-catenin (bcat). In the absence of Wnt signals, bcat is targeted for destruction [2] , keeping intracellular bcat levels low, and Wnt target genes are repressed by TCF/LEF family DNA-binding proteins and their co-repressor Groucho. Wnt ligands inactivate the destruction complex, bcat levels rise and it outcompetes Groucho for TCF/LEF binding, driving expression of Wnt target genes. However, bcat has a dual life in a different cellular location, as part of the cadherin-catenin complex that is key to cell adhesion [3] . As a result, studying bcat's role in Wnt signaling and cell fate decisions is complicated by the fact that removing it compromises adhesion and Wnt signaling simultaneously, and sorting out which influence is critical is challenging. Valenta et al. [4] , as reported in a recent issue of Genes and Development, describe a method to distinguish between bcat's roles in adhesion and Wnt signaling, which also provides insights into how the same transcriptional regulator regulates different suites of genes.
bcat binds TCF, the destruction complex, and E-cadherin using the same protein interaction surface -its central Armadillo (Arm) repeats ( Figure 1A,B) . However, bcat's amino and carboxyl termini are exposed for protein interactions [5] . At Wnt response elements, TCF binds DNA while bcat's amino-and carboxy-terminal regions recruit chromatin remodeling and basic transcription machinery ( Figure 1C ). The amino-terminal Arm repeats recruit both the Bcl9/Pygopus (Bcl9 = fly Legless) co-activator complex and Pontin 52, which links bcat to TATA-Box binding protein. Multiple proteins bind bcat's carboxy-terminal Arm repeats and unstructured region, including chromatin-modifying and remodeling factors like the histone acetyltransferases CBP/p300 and TRRAP-TIP60, as well as Brg1/Brahma and ISW1 [5] . bcat's carboxyl terminus also binds Parafibromin/Hyrax and MED12, which modulate transcriptional initiation and elongation by directly interacting with RNA polymerase II. Interestingly, fusing bcat's carboxyl terminus to TCF is sufficient to activate Wnt signaling [6] . bcat's carboxyl terminus also binds negative regulators of signaling like Chibby and ICAT. How the interplay of bcat's different interactors affects chromatin remodeling, transcription initiation and elongation is yet to be determined.
Previous work with fly bcat (Armadillo; Arm) revealed that one can generate mutations differentially affecting adhesion or signaling [7] . To explore which defects associated with loss of bcat are due to failure in Wnt signaling versus cell adhesion, Valenta et al. [4] designed mutations in fly and mammalian bcat specifically disrupting bcat's transcriptional interfaces. They mutated the Bcl9/Legless binding site, truncated bcat to delete the carboxyl terminus and prevent recruitment of carboxy-terminal partners, or made a double mutant abolishing both interacting surfaces ( Figure 1B ). These mutations disrupted bcat/Arm-dependent transcription in fly and human cultured cells, and had the expected effects in flies: most important, the bcat double mutant maintained cell adhesion but couldn't activate Wnt target genes.
These tools provided the means to specifically block bcat's Wnt signaling function and to separately target each of its transcriptional interfaces. Valenta et al. [4] produced knock-in mouse alleles of all three bcat mutants.
Deleting bcat's carboxyl terminus led to failure in gastrulation, similar to a bcat knockout, suggesting the carboxyl terminus is essential for Wnt signaling in mice (bcat knockout mice do not have earlier adhesion-related defects because the paralog plakoglobin covers some adhesive functions). In contrast, mutants lacking the Bcl9 binding site only had defects at later stages (E10.5). However, loss of the Bcl9 interaction reduced expression of Wnt target genes, suggesting that the Bcl9 interaction plays important roles in Wnt signaling in certain tissues. Using conditional knockouts, Valenta et al. showed nicely that defects in neural tube development of bcat knockout mice are more severe than those of bcat double mutant mice, due to failure of cell adhesion in the former but not the latter. Surprisingly, however, effects on neuronal progenitor specification were more severe in bcat double mutant than bcat knockout mice, suggesting disruption of bcat's functions in Wnt signaling and in adhesion can influence cell fate independently. It will be interesting to investigate mechanisms leading to reversal of the Wnt signalling defects when adhesion is disrupted.
Nearly all core components of the Wnt pathway are represented by multiple genes, making studying signaling challenging. Dominant-negative forms of TCF lacking the bcat-binding site are commonly used to circumvent this [8, 9] , but since TCFs associate with repressors like Groucho, over-expressing dominant-negative TCF may cause artifacts by repressing genes that usually are expressed at low levels in bcat's absence. Valenta et al.'s bcat double mutant can associate with TCFs, displacing any co-repressors, but cannot activate target gene transcription. This provides both mouse and fly researchers with a tool to turn off Wnt signalling globally and independently of TCF.
These results also have important implications for how the same signaling pathway works at different times and places to mediate distinct cell fate choices. Ultimately, this comes down to a choice of target genes: Wnt signaling must elicit very different transcriptional programs in different cells. How does the same bipartite transcription factor elicit these distinct responses? The work of Valenta et al. [4] suggests that different protein interfaces on bcat may regulate different cell fate choices. While the multiple interactions mediated by bcat's carboxy-terminal domain are critical for Wnt-mediated patterning events during gastrulation, the amino-terminal interface is not. However, the amino-terminal interface is important later, with roles in the forebrain, pharyngeal arches and craniofacial development. At the moment, these distinctions are relatively coarsely defined, because the carboxy-terminal deletion disrupts multiple protein interactions that may each serve more tissue-specific roles. Carboxy-terminal interactions may be broadly critical for regulating diverse Wnt target genes; alternatively, more detailed dissection of the or the amino and carboxyl termini (reviewed by [5, 18] ). Mutations used by Valenta et al. [4] are indicated in red; D164A disrupts the Bcl9-binding site, and truncation of the carboxyl terminus at 673 abolishes bcat's association with multiple players in the transcription machinery.
carboxy-terminal domain may reveal similar tissue-specific roles.
Two recent papers in Cell provide examples of mechanisms by which particular protein interfaces on bcat may create tissue-specific transcriptional outputs [10, 11] . The Young and Zon labs explored how BMP or Wnt signals produce tissue-specific transcriptional responses. They demonstrated that particular suites of target genes are activated only when SMAD or TCF transcription factors bind sites adjacent to those occupied by cell-type-specific master regulators like C/EBPa, GATA1, Myod1, or PU.1. One speculative possibility is that if TCF/bcat binds cooperatively with master regulators, particular protein interfaces on bcat and the protein(s) they recruit may each mediate interactions with a subset of these tissue-specific factors, explaining the different phenotypic consequences of disrupting them. This can now be explored directly.
The diversity of interfaces by which bcat interacts with transcriptional machinery also provides raw material on which evolutionary forces can act. Perhaps in ancestral bcat, amino-terminal and carboxy-terminal interactions were mutually reinforcing and thus somewhat redundant. This would open the way for natural variations in effectiveness of each interacting surface to become fixed in particular lineages. Valenta et al. [4] provide exciting insights into this. In Drosophila both Arm's carboxyl terminus [12] and its amino-terminal interacting partner Legless [13] are important for Wnt signaling. Valenta et al. support and extend this. Their data along with earlier work on fly Legless [13] and its interacting partner Pygopus [14] suggest that the amino-terminal interaction is broadly critical for Wnt signaling. In contrast, the data of Valenta et al. [4] along with earlier work [12] suggest that Arm's carboxy-terminal domain plays more of a quantitative role in enhancing signal output. The results in cultured mammalian cells and mice were strikingly different. In mouse fibroblasts, bcat's carboxy-terminal domain was substantially more important for regulation of endogenous Wnt target genes than the Bcl9 interaction surface [4] , and loss of the carboxy-terminal domain affected mouse embryonic development significantly more dramatically. These data suggest that in mammals the importance of the Bcl9 interaction has been reduced. Consistent with this, mice lacking both Pygopus paralogs have relatively subtle, tissue-specific impairments [15] . The most stringent test of this, double knockout of Bcl9 and its paralog Bcl9l, remains to be accomplished. The strong prediction is that this mutant will also have relatively subtle phenotypes. In fact, Bcl9/Pygopus may act largely as an anti-repressor of Wnt target genes by antagonizing Groucho, since groucho pygopus double mutant flies can activate Wnt targets [16] . Perhaps in mice other proteins compensate for loss of Bcl9/Pygopus to antagonize Groucho-mediated repression.
This new set of tools from the Basler group point the way ahead to sorting out how the same transcriptional activator can regulate distinct sets of target genes. Following their lead promises to provide insights into this central question in developmental biology, with the many interfaces of bcat providing the critical clues.
